Reps. Maloney, Clyburn Launch Investigation Into Emergent BioSolutions' Profits and Performance Under Federal Vaccine Contracts
April 20, 2021
April 20, 2021
WASHINGTON, April 20 -- Rep. Carolyn Maloney, D-New York, chair of the House Oversight and Reform Committee, issued the following news release on April 19, 2021:
Rep. Carolyn B. Maloney, Chairwoman of the House Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent a letter to the top executives of Emergent BioSolutions, Inc., launching an investigation into whether the company leveraged its relationship with . . .
Rep. Carolyn B. Maloney, Chairwoman of the House Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent a letter to the top executives of Emergent BioSolutions, Inc., launching an investigation into whether the company leveraged its relationship with . . .